| [1] |
Knechtle SJ, Kwun J. Unique aspects of rejection and tolerance in liver transplantation[J]. Semin Liver Dis, 2009, 29(1):91-101.
|
| [2] |
Samonakis DN, Germani G, Burroughs AK. Immunosuppression and HCV recurrence after liver transplantation[J]. J Hepatol, 2012, 56(4):973-983.
|
| [3] |
Ha M, Kim VN. Regulation of microRNA biogenesis[J]. Nat Rev Mol Cell Biol, 2014, 15(8):509-524.
|
| [4] |
Jeker LT, Bluestone JA. MicroRNA regulation of T-cell differentiation and function[J]. Immunol Rev, 2013, 253(1):65-81.
|
| [5] |
Dweep H, Gretz N. miRWalk2.0: a comprehensive atlas of microRNA-target interactions[J]. Nat Methods, 2015, 12(8):697.
|
| [6] |
Chen Y, Liang S, Long F, et al. Augmenter of liver regeneration attenuates acute rejection after rat liver transplantation[J]. Am J Surg, 2016, 212(1):128-137.
|
| [7] |
Morita M, Chen J, Fujino M, et al. Identification of microRNAs involved in acute rejection and spontaneous tolerance in murine hepatic allografts[J]. Sci Rep, 2014(4):6649.
|
| [8] |
Mashima R. Physiological roles of miR-155[J]. Immunology, 2015, 145(3):323-333.
|
| [9] |
Li J, Gong J, Li P, et al. Knockdown of microRNA-155 in Kupffer cells results in immunosuppressive effects and prolongs survival of mouse liver allografts[J]. Transplantation, 2014, 97(6):626-635.
|
| [10] |
Yang HY, Barbi J, Wu CY, et al. MicroRNA-17 modulates regulatory T cell function by targeting co-regulators of the Foxp3 transcription factor[J]. Immunity, 2016, 45(1):83-93.
|
| [11] |
Jeker LT, Zhou X, Gershberg K, et al. MicroRNA 10a marks regulatory T cells[J]. PLoS One, 2012, 7(5):e36684.
|
| [12] |
Gao M, Wang X, Zhang X, et al. Attenuation of cardiac dysfunction in polymicrobial sepsis by microRNA-146a is mediated via targeting of IRAK1 and TRAF6 expression[J]. J Immunol, 2015, 195(2):672-682.
|
| [13] |
Baumjohann D, Ansel KM. MicroRNA-mediated regulation of T helper cell differentiation and plasticity[J]. Nat Rev Immunol, 2013, 13(9):666-678.
|
| [14] |
Khan MA, Moeez S, Akhtar S. T-regulatory cell-mediated immune tolerance as a potential immunotherapeutic strategy to facilitate graft survival[J]. Blood Transfus, 2013, 11(3):357-363.
|
| [15] |
Alpdogan O, van den Brink MR. Immune tolerance and transplantation[J]. Semin Oncol, 2012, 39(6):629-642.
|
| [16] |
张剑，张琪，姜楠，等．CTLA4Ig和CD40LIg基因修饰骨髓间充质干细胞在异种胰岛移植排斥反应中的作用[J]．第三军医大学学报，2011,33(23):2450-2453.
|
| [17] |
Lu LF, Boldin MP, Chaudhry A, et al. Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses[J]. Cell, 2010, 142(6):914-929.
|
| [18] |
Echavarria R, Mayaki D, Neel JC, et al. Angiopoietin-1 inhibits toll-like receptor 4 signalling in cultured endothelial cells: role of miR-146b-5p[J]. Cardiovasc Res, 2015, 106(3):465-477.
|
| [19] |
Park H, Huang X, Lu C, et al. MicroRNA-146a and microRNA-146b regulate human dendritic cell apoptosis and cytokine production by targeting TRAF6 and IRAK1 proteins[J]. J Biol Chem, 2015, 290(5):2831-2841.
|
| [20] |
Berga-Bolaños R, Drews-Elger K, Aramburu J, et al. NFAT5 regulates T lymphocyte homeostasis and CD24-dependent T cell expansion under pathologic hypernatremia[J]. J Immunol, 2010, 185(11):6624-6635.
|
| [21] |
Li W, Kong LB, Li JT, et al. MiR-568 inhibits the activation and function of CD4+ T cells and Treg cells by targeting NFAT5[J]. Int Immunol, 2014, 26(5):269-281.
|